Institute-Clinical Outcomes Palo Alto, CA - 94304

Institute-Clinical Outcomes is categorized under Noncommercial Research Organizations in Palo Alto, CA and active since 2005.

Institute-Clinical Outcomes was established in 2005, and today employs 1 to 4, earning Unknown per year. This is a Noncommercial Research Organizations business, which does work in the B2B market, and is classified as a Noncommercial Research Organizations, under code number 5419100 by the NAICS.

If you are seeking more information, feel free to contact Alka Mithal, Owner at the company’s single location by writing to 703 Welch Road # F5, Palo Alto, California CA 94304 or by phoning (650) 780-0200. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Institute-Clinical Outcomes
Contact Person: Alka Mithal, Owner
Address: 703 Welch Road # F5, Palo Alto, California 94304
Phone Number: (650) 780-0200
Annual Revenue (USD): Unknown
Founded: 2005
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Noncommercial Research Organizations
SIC Code: 8733
NAICS Code: 5419100
Share This Business:

Institute-Clinical Outcomes was started in 2005 to provide professional Noncommercial Research Organizations under the SIC code 8733 and NAICS code 5419100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.

Feel free to contact Alka Mithal, Owner for inquiries that concern Institute-Clinical Outcomes by calling the company number (650) 780-0200, as your correspondence is most welcome. Additionally, the physical location of the single location of Institute-Clinical Outcomes can be found at the coordinates 37.434869,-122.17923 as well as the street address 703 Welch Road # F5 in Palo Alto, California 94304.

For its online presence, you may visit Institute-Clinical Outcomes’s website at and engage with its social media outlets through on Twitter and on Facebook.